COVIDIEN EVERFLEX SELF-EXPANDING PERIPHERAL STENT WITH ENTRUST DELIVERY SYSTEM LONG; STENT, SUPERFICIAL FEMORAL ARTERY
|
Back to Search Results |
|
Model Number EVD35-07-150-120 |
Device Problems
Activation, Positioning or Separation Problem (2906); Material Deformation (2976)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 05/30/2023 |
Event Type
malfunction
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
A physician was attempting to implant an everflex entrust for treatment of a 130mm plaque lesion in the distal region of the superficial femoral artery.The artery diameter was 6mm with moderate calcification and tortuosity.The device was prepped as per the ifu with no issues identified.No embolic protection was used.A 6fr non medtronic sheath was used.It is unknown if the lesion was pre-dilated.It was reported while retracting the thumb wheel physician a snap was heard and was unable to continue to deploy stent.The physician gently removed device allowing for stent to be deployed.Stent elongation occurred, an angio was taken of the implanted stent and he decided to leave alone.It was reported the patient had multiple interventions, the patient had several btk interventions which was not a result of the implanted stent.
|
|
Manufacturer Narrative
|
Image analysis the customer returned one image for evaluation.Image 1: the image is one image of a fully deployed stent in the likely r sfa, though this is zoomed in and there are no landmarks.Product analysis the handle was returned in two parts, the deployment wheel and pull wire were detached from the silver retractable isolation sheath.The stent was not returned.The device was returned with kinks observed to the gold isolation sheath, kinks were observed on the gold isolation sheath at approx.15.5cm,25cm, 39.5cm, 59.5cm and 80cm when measured from the distal end no functional testing could be carried out due to the condition of the returned device.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|
|
|